IL33 and pulmonary fibrosis: (88) utilized IL-33 in a bleomycin-induced inflammation and Idiopathic pulmonary fibrosis model using mouse IL-33 receptor [tumorigenic 2 (ST2) chain-inhibited] mice compared to C57BL/6 wild-type mice.